Columbus Circle Investors’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | – | Sell |
-23,924
| Closed | -$251K | – | 180 |
|
2017
Q3 | $251K | Sell |
23,924
-27,213
| -53% | -$286K | ﹤0.01% | 252 |
|
2017
Q2 | $564K | Buy |
51,137
+7,315
| +17% | +$80.7K | 0.01% | 226 |
|
2017
Q1 | $424K | Sell |
43,822
-5,493
| -11% | -$53.1K | 0.01% | 258 |
|
2016
Q4 | $512K | Sell |
49,315
-256
| -0.5% | -$2.66K | 0.01% | 243 |
|
2016
Q3 | $615K | Sell |
49,571
-13,242
| -21% | -$164K | 0.01% | 257 |
|
2016
Q2 | $675K | Buy |
62,813
+32,458
| +107% | +$349K | 0.01% | 239 |
|
2016
Q1 | $335K | Sell |
30,355
-43,060
| -59% | -$475K | ﹤0.01% | 248 |
|
2015
Q4 | $896K | Sell |
73,415
-30,420
| -29% | -$371K | 0.01% | 244 |
|
2015
Q3 | $1.69M | Sell |
103,835
-12,574
| -11% | -$205K | 0.01% | 230 |
|
2015
Q2 | $2.47M | Sell |
116,409
-11,596
| -9% | -$246K | 0.02% | 239 |
|
2015
Q1 | $2.3M | Buy |
128,005
+15,513
| +14% | +$279K | 0.02% | 249 |
|
2014
Q4 | $1.93M | Buy |
+112,492
| New | +$1.93M | 0.01% | 245 |
|
2014
Q1 | – | Sell |
-58,132
| Closed | -$468K | – | 285 |
|
2013
Q4 | $468K | Sell |
58,132
-38,125
| -40% | -$307K | ﹤0.01% | 281 |
|
2013
Q3 | $631K | Buy |
96,257
+17,246
| +22% | +$113K | ﹤0.01% | 282 |
|
2013
Q2 | $485K | Buy |
+79,011
| New | +$485K | ﹤0.01% | 266 |
|